Meeting rising demands of a new radiotheranostic era
European Pharmaceutical Review
AUGUST 31, 2023
In addition, radionuclide therapy has the potential to achieve high efficacy rates since the administered drugs spare surrounding healthy tissue, thus, reducing the burden on the patient. 1-4 Besides these drug products, several companies worldwide are developing radiotheranostics in clinical trials built on various radionuclides.
Let's personalize your content